- Synonyms(6S,9S,12R,15S,18S)-18-((S)-2-((S)-3-(1H-imidazol-5-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)propanamido)-3-(1H-indol-3-yl)propanamido)-1,1-diamino-6-((S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl)-15-(4-hydroxybenzyl)-9,12-diisobutyl-8,11,14,17-tetraoxo-2,7,10,13,16-pentaazanonadec-1-en-19-ylace...
- Description
(6S,9S,12R,15S,18S)-18-((S)-2-((S)-3-(1H-imidazol-5-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)propanamido)-3-(1H-indol-3-yl)propanamido)-1,1-diamino-6-((S)-2-(ethylcarbamoyl)pyrrolidine-1-carbonyl)-15-(4-hydroxybenzyl)-9,12-diisobutyl-8,11,14,17-tetraoxo-2,7,10,13,16-pentaazanonadec-1-en-19-ylacetate
Leuprolide (Leuprorelin) EP Impurity D is a fully characterized chemical compound used as a reference standard of API Leuprolide. The standard offered is compliant with regulatory guidelines. Leuprolide (Leuprorelin) EP Impurity D is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1926163-25-8
Related products
Leuprorelin EP Impurity G (Leuprolide EP Impurity G)

M.F.
M.W. 1209.42
CAT# AR-L01442
CAS# 112710-57-3